Exploring causal association between circulating inflammatory cytokines and functional outcomes following ischemic stroke: A bidirectional Mendelian randomization study

• Published in: European journal of neurology Vol. 31; no. 2; pp. e16123 - n/a
• Main Authors: Liu, Huacong, Liu, Zhaoxing, Huang, Yumeng, Ding, Qian, Lai, Zhenyi, Cai, Xiaowen, Huang, Shengtao, Yin, Lianjun, Zheng, Xiaoyan, Huang, Yong, Chen, Junqi
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.02.2024
• Subjects: Cell activation; Cytokines; Eotaxin; functional outcomes; Genetic diversity; Genomes; GWAS; Inflammation; inflammatory cytokines; Interleukin 18; Ischemia; ischemic stroke; Leukocytes (eosinophilic); Mendelian randomization; Observational studies; Randomization; RANTES; Stroke; Variance analysis; functional outcomes; GWAS; Mendelian randomization; inflammatory cytokines; ischemic stroke
• ISSN: 1351-5101; 1468-1331; 1468-1331
• DOI: 10.1111/ene.16123

Objectives Previous observational studies have indicated correlations between various inflammatory cytokines and functional outcomes following ischemic stroke (IS); however, the causality remains unclear. We aimed to further evaluate the causal association between 41 circulating inflammatory cytokines and functional outcomes following IS. Methods Two‐sample bidirectional Mendelian randomization (MR) analysis was used in this study. The genetic variation of 41 circulating inflammatory cytokines were derived from genome‐wide association study (GWAS) data of European ancestry (n = 8293). The corresponding genetic association of functional outcomes following IS were derived from European ancestry GWAS data (n = 6021). Results Inverse variance weighted (IVW) analysis showed that genetically predicted increased levels of regulation and activation in normal T‐cell expression and secretion factor (RANTES/CCL5) and eosinophilic chemotactic factor (EOTAXIN/CCL11) were positively correlated with the increased adverse functional outcomes (modified Rankin Scale [mRS≥3] following IS (OR: 1.40, 95% CI: 1.002–1.96, p = 0.049; OR: 1.33, 95% CI: 1.15–1.54, p = 0.0001). Interleukin 18 (IL‐18) level might be the downstream consequence of adverse functional outcomes following IS (β: −0.09, p = 0.039). Other inflammatory cytokines and functional outcomes following IS did not appear to be causally related. Conclusions This study suggests a causality between inflammation and adverse functional outcomes following IS. RANTES (CCL5) and EOTAXIN (CCL11) may be the upstream factors of adverse functional outcomes following IS, while IL‐18 may be the downstream effect of adverse functional outcomes following IS. Whether these cytokines can be used to predict or improve adverse functional outcomes after IS requires further researches.